Los Angeles-based Cedars-Sinai has developed a publicly available database that can be used to study adverse medication events — a $500 billion issue and the fourth leading cause of death in the U.S. Researchers at the health system compiled data…

The FDA is preparing to scale back on routine drug inspections following widespread layoffs in support staff, multiple officials told CBS News.  Around 170 employees were cut from the FDA’s Office of Inspections and Investigations, according to two health officials…

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian cancer.  A phase 3 trial found that relacorilant, when combined with chemotherapy drug nab-paclitaxel, improved progression free survival compared to the chemotherapy alone, according to…

Yale New Haven (Conn.) Health opened its sixth retail pharmacy April 1, according to a news release shared with Becker’s.  The new pharmacy, located on the first floor of Bridgeport (Conn.) Hospital, operates Monday through Friday from 8 a.m. to…

CVS Caremark, Express Scripts and Optum Rx — the three largest pharmacy benefit managers in the U.S. — each excluded more than 600 drugs from their 2025 formularies, according to an April 1 blog post from the Drug Channels Institute.…

A Senate bipartisan working group that focuses on the 340B program recently welcomed three new members.  On March 21, Sens. Tim Kaine, D-Va., Markwayne Mullin, R-Okla., and John Hickenlooper, D-Colo., joined the cohort, which also includes Sens. Jerry Moran, R-Kan.,…

Eli Lilly is broadening its direct-to-consumer approach by partnering with a digital health company, Noom, which is focused on weight management.  The collaboration connects Noom users with Eli Lilly’s pharmacy provider, GiftHealth, to facilitate access to Zepbound single-dose vials for…

A new study found that experimental drug lepodisiran significantly reduced levels of lipoprotein (a), a genetically inherited risk factor for heart disease, for up to a year.  The findings, published in The New England Journal of Medicine, involved 320 participants…

As Orlando Health-Health Central Hospital’s new CFO, Jennifer Mojica brings experience from holding various roles within the organization since 2006.  In an interview with Becker’s, Ms. Mojica discussed how her experiences and roles have shaped her leadership style and her…

Novo Nordisk’s diabetes pill Rybelsus, an oral semaglutide, reduced the risk of major heart-related events by 14% in adults with Type 2 diabetes and cardiovascular disease or chronic kidney disease, according to results from a stage 3 trial.  The findings,…